Retroperitoneal sarcoma--the continued challenge for surgery and oncology

Area of Science:

• Oncology
• Surgical Oncology

Background:

• Retroperitoneal sarcomas (RS) are rare malignant neoplasms with low incidence.
• Tumors are often large due to slow growth and subtle symptoms, complicating diagnosis and treatment.
• Histologic diversity and rarity hinder comparative studies and treatment evaluation.

Purpose of the Study:

• To review the challenges and outcomes associated with the surgical management of retroperitoneal sarcomas.
• To highlight the importance of complete tumor excision and its impact on patient survival.
• To emphasize the need for collaborative research and data collection for advancing treatment strategies.

Main Methods:

• Review of published literature on retroperitoneal sarcoma treatment and outcomes.
• Analysis of surgical resection rates, radicality, and recurrence data.
• Correlation of histological grade and surgical completeness with patient survival.

Main Results:

• Radical "en-block" resection is the preferred treatment, but achieving adequate margins is difficult.
• Resectability rates vary widely (38-100%), with significant local recurrence (33-86%).
• Complete excision and tumor grade significantly influence survival; 5-year survival ranges from 62-92% for well-differentiated to 16-48% for poorly differentiated sarcomas.

Conclusions:

• Complete surgical resection is the most critical factor for improving survival in retroperitoneal sarcoma patients.
• Local recurrence remains a significant challenge, often leading to treatment failure.
• International registries and cooperative studies are essential for advancing multimodal therapies and improving outcomes for these rare tumors.